MENU
PRME
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Prime Medicine (PRME) Earnings Date & Reports

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing... Show more

A.I. Advisor
published Earnings

PRME is expected to report earnings to rise 34.38% to -43 cents per share on February 27

Prime Medicine PRME Stock Earnings Reports
Q4'25
Est.
$-0.43
Q3'25
Beat
by $0.11
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.18
The last earnings report on November 07 showed earnings per share of -31 cents, beating the estimate of -43 cents. With 2.16M shares outstanding, the current market capitalization sits at 689.55M.
View a ticker or compare two or three
PRME
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PRME showed earnings on November 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
21 Erie Street
Phone
+1 617 564-0013
Employees
234
Web
https://www.primemedicine.com